Here are the five latest drugs or medical devices approved by the Food and Drug Administration this week.
- Betrixaban represents the first oral and long-lasting treatment to prevent deep vein thrombosis and pulmonary embolisms in acutely ill nonsurgical patients.
- The Oncomine Dx Target Test assesses tumor samples for the presence of biomarkers associated with three drug therapies approved to treat non-small cell lung cancer.
- Nevisense is a device intended to help clinicians detect early stages of malignant melanoma.
- The ClearLLab test detects several types of blood and lymphatic cancers.
- Illumina's next-generation sequencing kit helps clinicians identify which patients are eligible for treatment with Amgen's cancer drug Vectibix.
More articles on supply chain:
New York City faces critical blood shortage
UPS' newest delivery vehicles? Golf carts
6 drug, device recalls in June